UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative period

International journal of gynecological cancer, 2019-11, Vol.29 (9), p.1411-1416

2019

Link zum Volltext

Verfügbarkeit prüfen

Sexual and Marital Dysfunction in Women With Gynecologic Cancer

International journal of gynecological cancer, 2017-03, Vol.27 (3), p.603-607

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e008338

2024

Link zum Volltext

Verfügbarkeit prüfen

Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies

Clinical and translational science, 2022-04, Vol.15 (4), p.954-966

2022

Link zum Volltext

Verfügbarkeit prüfen

Priorities in Fertility Decisions for Reproductive-Aged Cancer Patients: Fertility Attitudes and Cancer Treatment Study

Journal of adolescent and young adult oncology, 2017-09, Vol.6 (3), p.435

2017

Link zum Volltext

Verfügbarkeit prüfen

Do Patient Characteristics Decide if Young Adult Cancer Patients Undergo Fertility Preservation?

Journal of adolescent and young adult oncology, 2017-06, Vol.6 (2), p.223

2017

Link zum Volltext

Verfügbarkeit prüfen

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)

HemaSphere, 2023-08, Vol.7 (S3), p.e49668c2

2023

Link zum Volltext

Verfügbarkeit prüfen

PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON‐HODGKIN LYMPHOMA (OLYMPIA‐4)

HemaSphere, 2023-08, Vol.7 (S3), p.e3061425-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies

Gynecologic oncology reports, 2019-11, Vol.30, p.100497-100497, Article 100497

2019

Link zum Volltext

Verfügbarkeit prüfen

Surgical management is associated with sexual dysfunction in gynecologic cancer

Cogent medicine, 2016-12, Vol.3 (1), p.1265277

2016

Link zum Volltext

Verfügbarkeit prüfen

Educational intervention for providers addressing the diversity gap in cervical cancer clinical study participation (579)

Gynecologic oncology, 2022-08, Vol.166, p.S282

2022

Link zum Volltext

Verfügbarkeit prüfen

Needs assessment for sexual health support following cancer diagnosis

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e23071-e23071

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial

JAMA health forum, 2020-06, Vol.3 (6), p.e207410-e207410

2020

Link zum Volltext

Verfügbarkeit prüfen

Fertility Attitudes and Cancer Treatment Study (FACTS)

Journal of clinical oncology, 2016-01, Vol.34 (3_suppl), p.112-112

2016

Link zum Volltext

Verfügbarkeit prüfen

Intracavitary Brachytherapy is Not Associated with Significant Change Ii Sexual Function: A Cross Sectional Study in Gynecologic Cancer Patients

Brachytherapy, 2018-07, Vol.17 (4), p.S17-S17

2018

Link zum Volltext

Verfügbarkeit prüfen

Sexual and marital dysfunction in women with gynecologic cancer: A multi-institutional, cross-sectional trial

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.9592-9592

2015

Link zum Volltext

Verfügbarkeit prüfen

Radiation therapy is not an independent risk factor for decreased sexual function in women with gynecologic cancers

Reports of practical oncology and radiotherapy, 2018-09, Vol.23 (5), p.331-336

2018

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy Use Is a Significant Predictor for Sexual Dysfunction in Women with Gynecologic Cancer

Journal of cancer therapy, 2017, Vol.8 (3), p.321-326

2017

Link zum Volltext

Verfügbarkeit prüfen

The exploration of fertility attitudes and the need for improved reproductive health services among reproductive-aged cancer patients

Flink, Dina Marie

2016

Link zum Volltext
ProQuest

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(20)
Dissertationen
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Humans
(6)
Oncology
(6)
Female
(4)
Patients
(4)
Adult
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Cancer
(3)
Middle Aged
(3)
Obstetrics & Gynecology
(3)
Retrospective Studies
(3)
Young Adult
(3)
Adolescent
(2)
Age
(2)
Antibodies
(2)
Antibodies, Bispecific
(2)
Antigens, Cd20
(2)
Cohort Studies
(2)
Decision Making
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative period

Sexual and Marital Dysfunction in Women With Gynecologic Cancer

Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies

Priorities in Fertility Decisions for Reproductive-Aged Cancer Patients: Fertility Attitudes and Cancer Treatment Study

Do Patient Characteristics Decide if Young Adult Cancer Patients Undergo Fertility Preservation?

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)

PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON‐HODGKIN LYMPHOMA (OLYMPIA‐4)

Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies

Surgical management is associated with sexual dysfunction in gynecologic cancer

Educational intervention for providers addressing the diversity gap in cervical cancer clinical study participation (579)

Needs assessment for sexual health support following cancer diagnosis

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA‐5)

Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial

Fertility Attitudes and Cancer Treatment Study (FACTS)

Odronextamab (REGN1979), a Human CD20 x CD3 Bispecific Antibody, Induces Durable, Complete Responses in Patients with Highly Refractory B-Cell Non-Hodgkin Lymphoma, Including Patients Refractory to CAR T Therapy

Intracavitary Brachytherapy is Not Associated with Significant Change Ii Sexual Function: A Cross Sectional Study in Gynecologic Cancer Patients

Sexual and marital dysfunction in women with gynecologic cancer: A multi-institutional, cross-sectional trial

Radiation therapy is not an independent risk factor for decreased sexual function in women with gynecologic cancers

Chemotherapy Use Is a Significant Predictor for Sexual Dysfunction in Women with Gynecologic Cancer

The exploration of fertility attitudes and the need for improved reproductive health services among reproductive-aged cancer patients

Suchergebnisse filtern